FXR activation mitigated tacrolimus-induced DM by regulating gluconeogenesis as well as glucose uptake of renal in a PGC1α/Foxo1-dependent manner (Li L. et al., 2019). The gene discussed is NR1H4; the disease is diabetes mellitus.